Ligand Pharmaceuticals Incorporated (LGND) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ligand Pharmaceuticals Incorporated, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 29.38x | -486.05x | 23.69x | -33.78x | 44.96x | -539.23x |
| P/B Ratio | 3.59x | 2.36x | 1.76x | 1.89x | 3.13x | 2.27x |
| P/S Ratio | 13.64x | 11.73x | 9.41x | 5.74x | 10.63x | 9.84x |
| Profitability | ||||||
| Gross Margin | 97.5% | 93.4% | 73.3% | 73.1% | 74.3% | 81.4% |
| Operating Margin | 17.6% | -13.5% | 9.1% | 1.5% | 43.0% | 22.9% |
| Net Margin | 46.4% | -2.4% | 39.7% | -17.0% | 23.7% | -1.8% |
| EBITDA Margin | 71.9% | 24.4% | 76.8% | 41.4% | 59.1% | 34.6% |
| Liquidity | ||||||
| Current Ratio | 22.23x | 8.93x | 14.15x | 2.67x | 11.15x | 5.00x |
| Quick Ratio | 21.98x | 8.55x | 12.72x | 2.53x | 10.50x | 4.74x |
| Leverage | ||||||
| Debt/Equity | 0.44x | 0.01x | 0.01x | 0.15x | 0.40x | 0.64x |
YoY = year-over-year change. Source: FMP..